Patient Outcomes

Patient Outcomes Medical Research Clinical Trials Patient Care Cancer Cancer Research Surgery Oncology Cancer Treatment Pharmacology

3 ARTICLES

2d ago

AI Tool FaceAge Published in The Lancet, Enhances Cancer Prognostic Accuracy

Mass General Brigham's FaceAge uses facial photos to estimate biological age, improving clinicians' predictions of survival outcomes for cancer patients.

3 ARTICLES

2d ago

4D Flow MRI Proven Superior for Diagnosing Aortic Stenosis in Landmark Study

4 ARTICLES

last wk.

Study Confirms Optimal Therapy Sequence for Rare Aggressive Lymphomas

15 ARTICLES

last wk.

Semaglutide Shows Potential to Transform Treatment of Advanced Fatty Liver Disease

4 ARTICLES

last wk.

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

3 ARTICLES

last mo.

New Prostate Cancer Surgery Technique Doubles Chance of Preserving Erectile Function

4 ARTICLES

last mo.

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

3 ARTICLES

2mo ago

Nasal Cartilage Cells Offer Breakthrough in Knee Injury Treatment

7 ARTICLES

2mo ago

Women and Minority Ethnic Doctors Now the Majority in UK for the First Time

6 ARTICLES

3mo ago

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Particle.news

Patient Outcomes

AI Tool FaceAge Published in The Lancet, Enhances Cancer Prognostic Accuracy

4D Flow MRI Proven Superior for Diagnosing Aortic Stenosis in Landmark Study

Study Confirms Optimal Therapy Sequence for Rare Aggressive Lymphomas

Semaglutide Shows Potential to Transform Treatment of Advanced Fatty Liver Disease

Study Confirms Nurse Shortages on NHS Wards Increase Patient Deaths and Costs

HSP-CAR30 Achieves Promising Results in Phase II Trial for Refractory Lymphomas

New Bone Marrow Test Doubles Survival for Some AML Patients, Study Confirms

FDA Reviews Pembrolizumab for Transformative Head and Neck Cancer Treatment

Mid-Afternoon Inhaler Use Found to Improve Asthma Control in New Study

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

New Prostate Cancer Surgery Technique Doubles Chance of Preserving Erectile Function

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

Nasal Cartilage Cells Offer Breakthrough in Knee Injury Treatment

Women and Minority Ethnic Doctors Now the Majority in UK for the First Time

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Never miss stories about

Patient Outcomes